Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Biosimilar Global Reference Standard Intrigues US FDA, But Many Questions Still To Answer

Oct 30 2017

• By Derrick Gingery

Twin girls are exercising on a lake shore, sprinkling water.

Related Content

Biosimilar Development Meetings At US FDA Not Just For Talking Similarity

Oct 31 2017

Biosimilars: US FDA Education Campaign Is Non-Committal On Non-Medical Switching

Oct 25 2017

Humira Biosimilar Settlement Could Be Model For Other Disputes

Sep 29 2017

Biosimilars: Adoption Of Global Reference Comparator Would Eliminate Bridging Studies

Aug 07 2017

Should A Biosimilar Sponsor Do The 'Patent Dance?' It Depends On Many Things

Aug 22 2017

Related Companies

AbbVie Inc.

Amgen, Inc.

Additional Topics

United States Europe Biosimilars FDA Regulation BioPharmaceutical

More from Biosimilars

More from Products

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window